![The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor | Annals of the Rheumatic Diseases The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/74/2/430/F2.large.jpg)
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor | Annals of the Rheumatic Diseases
![Use of abatacept in rheumatoid arthritis Recommendations based on current evidence | Semantic Scholar Use of abatacept in rheumatoid arthritis Recommendations based on current evidence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6c1411572b7863835c46bf34f23857ac34526c3a/7-Figure1-1.png)
Use of abatacept in rheumatoid arthritis Recommendations based on current evidence | Semantic Scholar
![Mechanism of action of abatacept. Under normal circumstances, CD80/86... | Download Scientific Diagram Mechanism of action of abatacept. Under normal circumstances, CD80/86... | Download Scientific Diagram](https://www.researchgate.net/publication/26767408/figure/fig1/AS:601674813030425@1520461862425/Mechanism-of-action-of-abatacept-Under-normal-circumstances-CD80-86-on.png)
Mechanism of action of abatacept. Under normal circumstances, CD80/86... | Download Scientific Diagram
![Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors | Published in Journal of Health Economics and Outcomes Research Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors | Published in Journal of Health Economics and Outcomes Research](https://jheor.org/article/23684-persistence-with-early-line-abatacept-versus-tumor-necrosis-factor-inhibitors-for-rheumatoid-arthritis-complicated-by-poor-prognostic-factors/attachment/61167.png)
Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors | Published in Journal of Health Economics and Outcomes Research
![Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2014/10/Paper-28178-abstract-27709-0.jpg)
Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts
![IJMS | Free Full-Text | Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis | HTML IJMS | Free Full-Text | Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis | HTML](https://www.mdpi.com/ijms/ijms-21-09067/article_deploy/html/images/ijms-21-09067-g001.png)
IJMS | Free Full-Text | Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis | HTML
![Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e](https://doctorlib.info/pharmacology/medical-pharmacology-therapeutics/medical-pharmacology-therapeutics.files/image257.jpg)
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
![Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment | HTML Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment | HTML](https://www.mdpi.com/cells/cells-10-00323/article_deploy/html/images/cells-10-00323-g001.png)
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment | HTML
![illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram](https://www.researchgate.net/profile/Andrew-Ostoer/publication/230769586/figure/fig1/AS:601685726609413@1520464464118/llustration-describing-the-mechanism-of-action-of-abatacept-Abatacept-has-high-affinity.png)
illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram
![Modern approaches to designing novel CD80 inhibitors that mimic biological effects of Abatacept | todaysclinician.com Modern approaches to designing novel CD80 inhibitors that mimic biological effects of Abatacept | todaysclinician.com](https://todaysclinician.com/wp-content/uploads/2016/04/TC-Apr-2016-022-Mechanism-of-T-cell-mediated-interactions.png)
Modern approaches to designing novel CD80 inhibitors that mimic biological effects of Abatacept | todaysclinician.com
![Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. | Semantic Scholar Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92d192da06f9050ad0d4b4d8649d8a09f115eccf/3-Figure3-1.png)